- Amended Statement of Ownership (SC 13G/A)
February 17 2009 - 11:09AM
Edgar (US Regulatory)
|
|
|
|
UNITED
STATES
|
|
|
SECURITIES
AND EXCHANGE COMMISSION
|
|
|
Washington,
D.C. 20549
|
|
|
|
|
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
Amendment No. 2
(Name of Issuer)
Common
Stock, par value $0.00001 per share
(Title of Class of
Securities)
(CUSIP Number)
William
Reiling
4351
Gulf Shore Blvd. North, Unit 6 North,
Naples,
FL 34103
(Name, Address and
Telephone Number of Person Authorized to Receive Notices and Communications)
(Date of Event Which
Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
o
|
Rule 13d-1(b)
|
o
|
Rule 13d-1(c)
|
x
|
Rule 13d-1(d)
|
CUSIP No.
74373C 10 7
|
|
|
(1)
|
Names of Reporting Person:
I.R.S. Identification Nos. of above person (entities only): NOT APPLICABLE
William Reiling
|
|
|
(2)
|
Check the Appropriate Box
if a Member of a Group:
|
|
|
(a)
|
o
|
|
|
(b)
|
o
|
|
|
(3)
|
SEC Use Only:
|
|
|
(4)
|
Citizenship:
United States
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
(5)
|
Sole Voting Power:
453,318
|
|
(6)
|
Shared Voting Power:
0
|
|
(7)
|
Sole Dispositive Power:
453,318
|
|
(8)
|
Shared Dispositive Power:
0
|
|
|
(9)
|
Aggregate Amount
Beneficially Owned by Each Reporting Person:
453,318
|
|
|
(10)
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares: NA
|
|
|
(11)
|
Percent of Class
Represented by Amount in Row (9):
5.4%
|
|
|
(12)
|
Type of Reporting Person:
IN
|
|
|
|
|
|
|
2
Item 1(a).
|
Name of Issuer:
ProUroCare Medical Inc.
|
Item 1(b).
|
Address of Issuers
Principal Executive Offices:
The address of the principal executive offices of the Issuer is 5500 Wayzata
Blvd., Suite 310, Wayzata, MN 55416.
|
|
Item 2(a).
|
Name of Person Filing:
William Reiling
|
Item 2(b).
|
Address of Principal
Business Office or, if none, Residence:
Reporting persons principal address is 4351 Gulf Shore Blvd. North, Unit 6
North, Naples, FL 34103.
|
Item 2(c).
|
Citizenship:
United States
|
Item 2(d).
|
Title of Class of Securities:
Common Stock, par value $0.00001 per share
|
Item 2(e).
|
CUSIP Number:
74373C 10 7
|
|
Item 3.
|
If this statement is filed pursuant
to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
|
Not Applicable
|
3
Item 4.
|
Ownership
|
|
(a)
|
Amount beneficially
owned:
453,318
|
|
(b)
|
Percent of class:
5.4%.
|
|
(c)
|
Number of shares to which
the person has:
|
|
|
(i)
|
Sole Voting Power:
453,318
|
|
|
(ii)
|
Shared Voting Power:
0
|
|
|
(iii)
|
Sole Dispositive Power:
453,318
|
|
|
(iv)
|
Shared Dispositive Power:
0
|
|
Item 5.
|
Ownership of Five Percent or Less
of a Class.
|
As of the date of this
report, as a result of the Companys issuance of additional shares of common
stock, the reporting person has ceased to be a beneficial owner of more than
5 percent of the class of securities.
If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than 5 percent of the class of securities, check the
following
x
|
|
Item 6.
|
Ownership of More than Five Percent
on Behalf of Another Person.
|
|
NOT APPLICABLE
|
|
Item 7.
|
Identification and Classification
of the Subsidiary Which Acquired the Security Being Reported on By the Parent
Holding Company or Control Person.
|
|
NOT APPLICABLE
|
|
Item 8.
|
Identification and Classification
of Members of the Group.
|
|
NOT APPLICABLE
|
|
Item 9.
|
Notice of Dissolution of Group.
|
|
NOT APPLICABLE
|
4
Item 10.
|
Certification.
|
|
NOT APPLICABLE
|
Signature
After reasonable inquiry and to the best of his and its knowledge and
belief, each of the following certifies that the information set forth in this
statement is true, complete and correct.
|
February 11, 2008
|
|
Date:
|
|
/s/ William Reiling
|
|
Signature:
|
|
William Reiling
|
|
Name/Title
|
5
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024